Loading...
Market
Dominant application of OpenCRISPR by end of 2026
5
Resolution / Starting Odds
Therapeutic applications • 25%
Research tools • 25%
Diagnostic tools • 25%
Personalized medicine • 25%
Scientific publications and industry reports.
Story
ProfluentBio Launches OpenCRISPR: AI-Generated Gene Editor with Modest Impact
Apr 23, 2024, 01:49 AM
ProfluentBio has announced the launch of OpenCRISPR, a groundbreaking open-source AI-generated gene editor. Developed using ProfluentBio's large language models, this tool includes a Cas9-like protein and guide RNA, designed to edit human DNA with modest on-target activity. The initiative, which aims to democratize access to gene editing technology, has the potential to revolutionize biomedicine but is not expected to impact clinical editing in the next 3 years. The sequences and molecules designed by AI have been freely released under the OpenCRISPR initiative, marking a significant milestone in personalized medicine.
View original story
Similar markets
Agriculture • 25%
Biomedicine • 25%
Veterinary • 25%
Biotechnology research • 25%
0-5 • 25%
6-10 • 25%
11-20 • 25%
More than 20 • 25%
Low (0-10 institutions) • 25%
Moderate (11-30 institutions) • 25%
High (31-50 institutions) • 25%
Very High (over 50 institutions) • 25%
Cancer Detection • 20%
Cardiac Imaging • 20%
Neurological Scans • 20%
Musculoskeletal Imaging • 20%
Other Applications • 20%
Electronic Health Records • 20%
Medical Imaging • 20%
Genomic Risk Assessments • 20%
Clinical Reasoning • 20%
Other • 20%
Education • 20%
Healthcare • 20%
Finance • 20%
Technology • 20%
Retail • 20%
Oncology • 25%
Neurodegenerative Diseases • 25%
Cardiovascular Diseases • 25%
Infectious Diseases • 25%
High adoption in diagnostics • 25%
High adoption in surgical assistance • 25%
High adoption in personalized medicine • 25%
Limited adoption across sectors • 25%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16 or more countries • 25%
Automated manufacturing • 25%
Precision agriculture • 25%
Emergency response robotics • 25%
Domestic helper robots • 25%